Trials / Recruiting
RecruitingNCT05752071
Gastrointestinal Stimulation As a Treatment of Postoperative Ileus Following Extensive Surgery
GaStrointestinal STIMULation As a Treatment of Postoperative IlEus Following Extensive Surgery (STIMULATE). -A Prospective Double-blinded Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to investigate the effect of gastrointestinal stimulation with a pacemaker on the length of postoperative bowel paralysis in patients undergoing major abdominal surgery due to metastasizing colorectal cancer, appendiceal cancer or pseudomyxoma peritonei. The main question it aims to answer is if the length of postoperative ileus is reduced when the gastrointestinal tract is stimulated with a pacemaker. All participants will undergo cytoreductive surgery +/- heated intraperitoneal chemotherapy (the standard treatment for colorectal cancer, appendiceal cancer with peritoneal carcinomatosis or pseudomyxoma peritonei). After surgery, but before the abdomen is closed a pace lead will be attached to the stomach, exteriorized trough the abdominal wall and connected to an external pacemaker. The pacemaker is either turned on (experimental group) or off (control group). After surgery, patients will be asked to fill out a diary on bowel movements once a day. Once normal bowel function is regained, the pace lead and pacemaker will be removed trough the abdominal wall with a firm pull.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Gastric electrical stimulation | Mounting of a temporary gastric pacemaker |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2027-06-01
- Completion
- 2027-09-01
- First posted
- 2023-03-02
- Last updated
- 2025-01-31
Locations
1 site across 1 country: Denmark
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05752071. Inclusion in this directory is not an endorsement.